Kv. Speeg et Al. Maldonado, EFFECT OF CYCLOSPORINE ON COLCHICINE PARTITIONING IN THE RAT-LIVER, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 434-436
Colchicine is secreted into bile as a major pathway of elimination. Cy
closporine (CsA) inhibits colchicine biliary secretion. In the present
study, the effects of cyclosporine and its vehicle (cremophor) on the
partitioning of colchicine across the liver were studied. CsA decreas
ed the colchicine bile/plasma ratio from 484+/-39 to 53+/-3 (P <0.001)
. This effect was due to both a decrease in bile/liver partitioning (c
ontrol, 35.1+/-1.2, vs CsA treatment, 9.2+/-0.5; p <0.001) as well as
a decrease in liver/plasma partitioning (conrol, 13.7+/-0.8, vs CsA tr
eatment, 5.7+/-0.4; P <0.001). Cremophor also decreased the colchicine
bile/plasma ratio (317+/-19, P <0.02 vs control), but this effect was
due to a decrease in the liver/plasma ratio (9.99+/-0.7, P <0.02 vs c
ontrol) rather than the bile/liver ratio (31.9+/-2.1, P >0.2 vs contro
l). Inhibition at the canalicular membrane is consistent with the loca
tion of gp-170, the presumed transporter of colchicine.